These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 30121177

  • 1. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G, Sanam K, Gholkar G, Bianco NR, Szymkiewicz S, Shah D.
    Int J Cardiol; 2018 Dec 01; 272():179-184. PubMed ID: 30121177
    [Abstract] [Full Text] [Related]

  • 2. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG.
    Pacing Clin Electrophysiol; 2014 May 01; 37(5):562-8. PubMed ID: 24762055
    [Abstract] [Full Text] [Related]

  • 3. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar 01; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

  • 4. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 5. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 15; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 6. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep 15; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 7. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA, Carrillo RG.
    Heart Rhythm; 2015 Jul 15; 12(7):1565-73. PubMed ID: 25839113
    [Abstract] [Full Text] [Related]

  • 8. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I.
    J Cardiovasc Electrophysiol; 2017 Jul 15; 28(7):778-784. PubMed ID: 28429542
    [Abstract] [Full Text] [Related]

  • 9. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 15; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 10. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 11. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 12. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar 27; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 13. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
    Jiang X, Ming WK, You JHS.
    J Cardiovasc Electrophysiol; 2019 Nov 27; 30(11):2387-2396. PubMed ID: 31502350
    [Abstract] [Full Text] [Related]

  • 14. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar 27; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 15. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK.
    J Heart Lung Transplant; 2015 Oct 27; 34(10):1305-9. PubMed ID: 26094085
    [Abstract] [Full Text] [Related]

  • 16. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul 27; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 17. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 18. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with wearable cardioverter defibrillators at a tertiary electrophysiology program.
    Bossory L, Schubert S, Afzal MR, Weiss R, Tyler J, Kalbfleisch S, Augostini R, Hummel J, Okabe T, Daoud EG, Houmsse M.
    Pacing Clin Electrophysiol; 2018 Nov 19; 41(11):1491-1494. PubMed ID: 30191582
    [Abstract] [Full Text] [Related]

  • 20. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections.
    Castro L, Pecha S, Linder M, Vogler J, Gosau N, Meyer C, Willems S, Reichenspurner H, Hakmi S.
    J Cardiothorac Surg; 2017 Nov 25; 12(1):99. PubMed ID: 29178898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.